Roya Nazarian
Dermatology Physician · New York, NY
Roya Nazarian is a dermatology physician with a practice address in New York, New York, and NPI 1831718949, issued on Apr 9, 2020. Check the license (New York 321200, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Roya Nazarian
- Primary taxonomy
- Dermatology Physician 207N00000X
- License number
- 321200 NY
Self-reported in NPPES; status is on the state search - Practice location
- 59 E 54TH St RM 71, New York, NY 10022
- Phone
- (212) 644-8581
- Enumerated
- Apr 9, 2020
- Record last updated
- Jul 26, 2024
- Medicare enrollment
- Enrolled (PECOS I20240821000956); accepts Medicare assignment
- Medical or professional school
- Icahn School Of Medicine At Mount Sinai, 2020
- Entity
- Type 1 · individual
8 nearest dermatology physician records → All 1,211 in New York → Look up another NPI →
Also registered at 59 E 54TH St RM 71
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Sheri Lagin, MDProcedural Dermatology Physician1669460416
- Ryan Turner, MDProcedural Dermatology Physician1710013586
Verify Roya Nazarian in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 321200Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
70% fewer Medicare Part D claims than the average dermatology physician in 2024
239 Medicare Part D claims for 75 beneficiaries, against an average of 797 among the 12,802 providers of this specialty who prescribed in Part D. Brand-name drugs were 11% of claims.
Most prescribed
- Ketoconazole44 claims
- Triamcinolone Acetonide27 claims
- Ammonium Lactate22 claims
- Hydrocortisone16 claims
- Clindamycin Phosphate14 claims
- Dupixent Pen12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $930.25
11 payments; by number, the most common kind was food and beverage; the largest payer was Janssen Biotech, Inc. The 10,250 providers of this specialty with any payment received $8,544.61 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Ryan B Turner MD PCNew York, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Roya Nazarian among 1,211 dermatology physician records in New York
Roya Nazarian is one of 1,211 dermatology physician records with a practice address in New York. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 91% of them.
- NPI issued2020 · 91% of these records are older, 6% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 73% of these records are
- Graduated2020 · median 2004 among the 880 with a school on file
- Record last updated2024 · 61% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207N00000X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Dermatology Physician providers in New York
There are 1,211 dermatology physician records in New York.
All 1,211 in New York → Every provider in New York → Dermatology Physician nationwide →
The 8 dermatology physician records with the nearest ZIP codes
- Arash Akhavan, M.D., F.A.A.D.New York, NY 100221013138874
- Diane BersonNew York, NY 100221184655078
- Karen Burke, MD, PHDNew York, NY 100221629286083
- Daniel Foitl, MDNew York, NY 100221861499147
- Bruce Katz, MDNew York, NY 100221154404895
- George Kihiczak Md Pc, MDNew York, NY 100221629276639
- Eric Kusseluk, M.D.New York, NY 100221235283367
- Anat Lebow, M.D.New York, NY 100221831211226
Common questions
What is Roya Nazarian's NPI number?
Roya Nazarian's National Provider Identifier (NPI) is 1831718949, issued on Apr 9, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Roya Nazarian located?
The NPPES record lists a practice address at 59 E 54TH St RM 71, New York, NY, 10022. Phone: (212) 644-8581. Providers update this record themselves, so call before visiting.
How can I verify Roya Nazarian's license?
NPPES lists New York license number 321200, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Roya Nazarian prescribe under Medicare Part D?
In 2024, Roya Nazarian had 239 Medicare Part D claims for 75 beneficiaries; the average among dermatology physician prescribers was 797. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.